M. K. Hourfar - Concepedia

Concepedia

Author

M. K. Hourfar

German Red Cross

Also Known As

M. K. HOURFAR, M. K. Hourfar, M.K. Hourfar, M.Kai Hourfar, Michael K Hourfar, Michael K. Hourfar, Michael Kai Hourfar, Rüdiger von Versen

35

Publications

1.3K

Citations

20

H-Index

21

Concepts

All Affiliations

German Red Cross Goethe University Frankfurt Paul Ehrlich Institut Austrian Red Cross Medical University of Vienna

MK

About

M. K. Hourfar is an author at German Red Cross specializing in medicine, virology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	335
2	Epidemiology	3	3	321
3	Public Health	2	2	287
4	Global Health	1	1	189
5	International Health	1	1	189

M. K. Hourfar

×

23

Publications

1.3K

Citations

20

H-Index

	Year	Citations
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus M. K. Hourfar, Christine Jork, Volkmar Schottstedt, Transfusion	2008	190
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 W. Kurt Roth, M.P. Busch, Annette Schuller, Vox Sanguinis Organ DonationNat TestingData S1 QuestionnaireBlood DonationsPublic Health	2011	189
Increase in human West Nile and Usutu virus infections, Austria, 2018 Stephan W. Aberle, Jolanta Kolodziejek, Christof Jungbauer, Eurosurveillance September 2018Disease OutbreakBlood Donation ScreeningArbovirusVector-borne Pathogen	2018	98
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany Michael Schmidt, Klaus Korn, C. Micha Nübling, Transfusion	2009	75
Anti‐HBc screening of blood donors: a comparison of nine anti‐HBc tests Michael Schmidt, C. Micha Nübling, Heinrich Scheiblauer, Vox Sanguinis	2006	70
Blood donor screening for parvovirus B19 in Germany and Austria Michael Schmidt, Anna Themann, Camilla Drexler, Transfusion	2007	68
Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion‐transmitted bacterial strains Michael Schmidt, M. K. Hourfar, Walid Sireis, Transfusion	2015	61
Hepatitis B virus genotype G monoinfection and its transmission by blood components Michael Chudy, Michael Schmidt, Volker Czudai, Hepatology	2006	59
Recipients potentially infected with parvovirus B19 by red blood cell products M. K. Hourfar, U. Mayr‐Wohlfart, Anna Themann, Transfusion	2010	44
High-Throughput Purification of Viral RNA Based on Novel Aqueous Chemistry for Nucleic Acid Isolation M. K. Hourfar, Uwe Michelsen, Michael Schmidt, Clinical Chemistry	2005	40

Page 1